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Sarafotoxin-b, a potent snake vasoconstrictor peptide homologous to the mammalian endothelial vasoconstrictor en- 
dothelin, induces phosphoinositide (PI) hydrolysis in various brain regions of the rat. Sarafotoxin-b induced PI hydrolysis 
is largely independent of extracellular Ca*+ and is detected in all brain regions where toxin-binding sites are found. These 
results point to the existence of a hitherto undetected neuroreceptor associated with the PI cycle. 
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1. INTRODUCTION 
SRTXs (in our previous paper we used SRT 
(without the X) as acronym for the sarafotoxin), a 
group of 21-residue cysteine-rich peptides [ 1,2] 
isolated from the venom of the snake A tractaspis 
engaddensis, were shown to activate the hydrolysis 
of phosphoinositides in a dose-dependent manner 
[3]. Thus, sarafotoxins appear to interact with and 
activate a specific phosphoinositide (PI) 
phosphodiesterase system, thereby triggering the 
PI cycle. This cycle is a major second-messenger 
system in brain and peripheral tissues; its trigger- 
ing by hormones and neurotransmitters results in 
the hydrolysis of phosphatidyl inositol 
bisphosphate to IP3 and diacylglycerol [4]. IP3 ac- 
tivates the release of calcium from intracellular 
Correspondence address: M. Sokolovsky, Laboratory of 
Neurobiochemistry, Dept of Biochemistry, George S. Wise 
Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, 
Israel 
Abbreviations: SRTX, sarafotoxin; PI, phosphoinositide; IPI, 
inositol-l-phosphate; IP2, inositol-1,Cbisphosphate; IP3, 
inositol-1,4,5trisphosphate; G,, guanine nucleotide binding 
protein present in the brain; G,, guanine nucleotide binding 
protein associated with phospholipase C 
stores [4], and diacylglycerol activates protein 
kinase C [5]. We therefore suggested that SRTXs 
might induce an increase in intracellular Ca2+ 
levels, which could account for their vasoconstric- 
tor activity and for the disturbances caused in the 
A-V conducting system [3,6]. 
As neither the binding nor the PI hydrolysis in- 
duced by SRTXs is affected by blockers or ac- 
tivators of known receptors or ion channels [3], it 
seems that this group of peptides might interact 
with a specific PI-receptor system which operates 
through a putative ‘SRTX-like’ neuromodulator, 
both in rat heart and rat brain. Support for this 
suggestion comes from the recent discovery of en- 
dothelin [7], an endogenous 21-residue cysteine 
rich vasoconstrictor peptide present in mammalian 
endothelial cells and showing a high degree of 
homology to SRTXs [3]. 
In the present communication we report on the 
localities of SRTX-b-induced phosphoinositide 
hydrolysis and their relationships with the densities 
of “‘I-SRTX binding sites. 
2. EXPERIMENTAL 
SRTX-b was isolated and purified to homogeneit;from the 
venom of the snake A. engadensis as described [1,2]. 
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Preparation of brain slices has been described in detail 181. 
Briefly, adult male Charles River derived (CD) rats were 
decapitated, their brains removed, dissected and sliced with a 
Sorval TC-2 tissue sectioner (200 x 200 rm). The formation of 
[3H]1Ps, [‘H]IPz and ]‘H]IPi in the tissue slices was assayed 191 
by the method of Berridge [lo]. Slices were prelabeled (60 min) 
with 60&i/ml of [‘Hlinositol (18.7 Ci/mmol, Amersham) in 
Krebs medium, washed 3 times with 5 mM inositol in the same 
medium. Packed slices (50/r]) were then incubated in Krebs 
medium (total volume 250 pl) containing 10 mM LiCl with and 
without SRTX-b. The reaction was terminated after 30 min (or 
as indicated in the text) by the addition of 1 ml 
chloroform/methanol (1:2), followed by 0.35 ml chloroform 
and 0.35 ml HzO. The water-soluble products were separated 
chromatographically on Dowex columns [lo] and counted with 
corrections for quenching. A sample from the lipid extract was 
also counted. All assays were performed in triplicate. Data are 
expressed in terms of [‘H]inositol phosphate formed as a 
percentage of total labeled [3H]inositol lipids. Zero time blanks 
were subtracted. 
Protein was determined by the Lowry method using bovine 
serum albumin as a standard. 
3. RESULTS 
Since the binding of SRTXs in the rat atrium 
was coupled to the hydrolysis of phosphoinositides 
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Fig.1. Time courses and specificity of SRTX-b-induced PI 
hydrolysis in cerebral and cerebellar tissue slices. Tissue slices 
from both brain regions were prelabeled with [3H]inositol and 
subjected to the PI hydrolysis assay in the absence and in the 
presence of lo-’ M SRTX-6, as detailed in section 2. The data 
represent basal and toxin-induced accumulation of [3H]IP1, 
expressed in terms of [‘H]IPr formed as a percentage of total 
[‘H]inositol lipids. Zero time blanks were subtracted. Values 
are means f SD (vertical bars) of triplicate samples. The 
following substances or ions failed to inhibit induction of PI 
hydrolysis by SRTX-b (IO-’ M): atropine (IOrM), curare 
(10 PM), haloperidol (10 pM), naloxone (lOrM), propranolol 
(IOpM), _ yohimbine (lO/cM), prazosin (0.1 ,uM), allersan 
(IOpM), tetrodotoxin (1 PM), tetraethylammonium (1 mM), 
nimodipine (1 fiM), verapamil (1 ,uM), cobalt (1 mM), 
-Ca’+ 
+EGTA 
Fig.2. Induction of PI hydrolysis by SRTX-b in the absence and 
in the presence of Ca*+. PI hydrolysis was determined in 
cerebellar tissue slices (30 min incubation time) as detailed in 
the legend to fig.1. The experiments were conducted with or 
without 1 mM CaC12, in the presence or absence of 1 mM 
manganese (1 mM). EGTA. Toxin concentration was 0.1 PM. 
131, we examined SRTX-b-induced PI hydrolysis in 
various regions of the rat brain. Initial experiments 
explored the time course of the formation of 
[3H]inositol phosphates in the presence of 10 mM 
LiCl in [3H]inositol-labeled tissue slices from the 
cerebellum and cortex. In both tissues, 0.1 PM 
SRTX-b induced a time-dependent increase in the 
formation of [3H]IPi: IPi was detected after a 
short lag period (5-7 min) and continued to in- 
crease almost linearly for at least 30 min (fig.1). 
The Ievels of (3H]IPz were very low compared to 
those of IPi, while [3H]IP3 was barely detectable 
(levels recorded were within the limits of ex- 
perimental error). 
SRTX-induced PI hydrolysis in the cerebellar 
and cerebral cortical tissue slices was not blocked 
by ligands of known receptors or ion channels 
(fig.1). Other experiments showed that PI 
hydrolysis could be induced by SRTX-b in a 
calcium-free medium, with and without 1 mM 
EGTA (fig.2). Even though the efficacy of the tox- 
in was reduced under these conditions, the ratio of 
the induced to basal hydrolysis remained un- 
changed (fig.2). We could not, however, demon- 
strate SRTX-b-induced PI hydrolysis in homo- 
L m basal 
0 SRTX-~ 
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Table 1 
Regional distribution of rZ51-SRTX-b binding sites and of 
SRTX-b-induced PI hydrolysis” 
Brain tissue rz51-SRTX-b binding SRTX-b-induced PI 
sites hydrolysis, 
(fmol/mg protein) toxin/basal 
Cerebellum 850 f 50 3.5 f 1 
Hypothalamus 440 f 10 1.4 f 2 
Thalamus 450 f 50 3.8 f 1 
Brain stem 320 f 10 4.2 f 1 
Olfactory bulb 200 f 50 4.2 + 0.2 
Spinal cord 140 * 20 2.5 f 0.2 
Hippocampus 150 f 10 5.2 f 1 
Caudate putamen 100 * 20 7.7 f 1 
Cerebral cortex 12 * 10 2.5 + 1 
a Data for binding densities were taken from [ll]. Values are 
means + SD of five separate determinations. PI hydrolysis is 
expressed as the ratio of SRTX-b (lo-’ M) induced formation 
of [3H]IPt (30 min) to basal (means + SD, three separate 
determinations) determined under the assay conditions 
specified in section 2 
genates of these tissues. The homogenates were 
derived from tissue slices prelabeled with [3H]in- 
ositol, and homogenized in a Ca*+-free medium 
containing 1 mM EGTA. In the resulting labeled 
membranes we were able to demonstrate a time- 
dependent increase in IPi in the presence of 1 mM 
Ca*+ (but not in its absence) and NaF, but not 
SRTX-b-stimulated PI hydrolysis. Thus, under the 
conditions employed here, SRTX-b-induced PI 
hydrolysis in the brain was detectable only in tissue 
slices. 
We then proceeded to measure the SRTX-b- 
induced formation of IPi in tissue slices from 
various brain regions. The results (expressed as 
toxin-induced PI hydrolysis over basal) are sum- 
marized in table 1 along with the density of ‘*‘I- 
SRTX binding sites. 
4. DISCUSSION 
In this study we characterized SRTX-b-induced 
PI hydrolysis in rat brain and its regional localities. 
In all brain regions studied we detected both 
SRTX-induced PI hydrolysis and 1251-SRTX 
binding [3,11]. Our results suggest hat the SRTX- 
b-binding sites are associated at least in part with 
the important PVacylglycerol second-messenger 
system [4,5] of the brain. Both in the brain and in 
the peripheral tissues, this system can be triggered 
by external stimuli produced by neurotransmitters, 
hormones, growth factors and chemoattractants 
which interact with their respective receptors. It 
may also be stimulated by the activation of ion 
channels leading to the entry of Ca*’ ions into cells 
[4]. Our observations on SRTX-b-induced PI 
hydrolysis in rat brain as well as in rat atrium [3] 
suggest that primary activity of SRTX-b is 
mediated via its own receptor and not via known 
ion channels since channel blockers such as 
tetrodotoxin, tetramethyl ammonium, nitren- 
dipine, cobalt and manganese failed to inhibit its 
activity. Consistent with this notion is the finding 
that SRTX-b can induce PI hydrolysis in the brain 
even in the absence of Ca*+ and in the presence of 
EGTA. Thus, SRTX-b appears to activate a 
neuroreceptor which is coupled to the PI cycle. It 
could have been assumed to interact with a known 
component(s) of this cycle such as PI 
phosphodiesterase or G, [12]. However, this 
assumption seems unlikely, since, in contrast to the 
SRTX-b binding sites, G, and G, are ubiquitous 
proteins (as reviewed in ref.13) and the latter is 
highly abundant in the brain. Moreover, the 
failure of SRTX-b (but not of Ca*+ or NaF) to in- 
duce PI hydrolysis in brain membranes prelabeled 
with [3H]inositol (whereas Ca*+ or NaF did ac- 
tivate such hydrolysis in these membranes) argues 
against direct activation of PI phosphodiesterase 
by SRTX-b. 
A comparison between the regional distribution 
of ‘251-SRTX receptors and the localities of SRTX- 
b-induced PI hydrolysis (table 1) shows no simple 
correlation between the two. For example, while 
the efficacy of the toxin is higher in the caudate 
than in the cerebellum, the density of 1251-SRTX-b 
sites in the latter is by far much higher than in the 
former. This phenomenon could be explained by 
the existence of two or more subtypes of receptors. 
Such a suggestion is in line with two independent 
observations: (a) SRTX-b binds with a much 
higher affinity (& = 0.3 nM) to the receptors of 
the caudate and cerebral cortex than to the recep- 
tors of the cerebellum or the rat atrium (& = 
3.5-4 nM). (b) In cultured epithelial cells, the 
closely related vasoconstrictor peptide endothelin 
was reported to induce Ca*+ influx but not PI 
hydrolysis [14]. Moreover, in other receptors 
coupled to PI hydrolysis such as the muscarinic 
389 
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receptors, lack of correlation between receptor 
distribution and the efficacy of agonist-mediated 
PI hydrolysis is attributed to the existence of recep- 
tor subtypes. 
As shown in fig.2, the extent of PI hydrolysis in 
the absence of Ca2+ (with EGTA) is lower than 
that observed in the presence of Ca’+. The partial 
inhibition of IPi formation might be explained by 
assuming coupling between the toxin-receptor and 
a voltage-independent Ca2+ channel. The rise in 
Ca2+ resulting from Ca2+ influx could thus lead at 
least in part to PI breakdown and IPl formation. 
Alternatively, the Ca2+ dependent increase in PI 
hydrolysis could be related to secondary processes 
resulting from the main pathway of PI hydrolysis 
[4,5] induced by the toxin. In this context it should 
be noted that the results of Hirata et al. [14], who 
showed that endothelin caused both sustained and 
transient increases in intracellular Ca2+ levels (only 
the former increase is blocked by EGTA), are com- 
patible with the above suggestion. 
The present results and the high degree of 
homology between endothelin and SRTXs [3] may 
suggest hat an endogenous ubstance ‘SRTX-like’ 
and/or ‘endothelin-like’ is present in the brain. 
Certain regions of the brain, such as the 
cerebellum, might contain high levels of this en- 
dogenous neuropeptide that interacts with the 
SRTX-receptor. 
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